These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8907129)

  • 1. Classification of positive inotropic actions based on electrophysiologic characteristics: where should calcium sensitizers be placed?
    Varro A; Papp JG
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S32-44. PubMed ID: 8907129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of calcium-sensitizing agents.
    Vegh A; Papp JG; Udvary E; Kaszala K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of positive inotropic substances].
    Godfraind T
    Ann Cardiol Angeiol (Paris); 1984; 33(4):197-201. PubMed ID: 6087713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure.
    Perrone SV; Kaplinsky EJ
    Int J Cardiol; 2005 Sep; 103(3):248-55. PubMed ID: 16098385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will calcium sensitizers play a role in the treatment of heart failure?
    Nielsen-Kudsk JE; Aldershvile J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S77-84. PubMed ID: 8907135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium.
    Hsu CH; Wei J; Chen YC; Yang SP; Tsai CS; Lin CI
    J Heart Lung Transplant; 2006 Sep; 25(9):1126-34. PubMed ID: 16962476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization.
    Bowman P; Haikala H; Paul RJ
    J Pharmacol Exp Ther; 1999 Jan; 288(1):316-25. PubMed ID: 9862786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In contrast to forskolin and 3-isobutyl-1-methylxanthine, amrinone stimulates the cardiac voltage-sensitive release mechanism without increasing calcium-induced calcium release.
    Xiong W; Moore HM; Howlett SE; Ferrier GR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):954-63. PubMed ID: 11504790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium sensitizers in chronic heart failure: inotropic interventions-reservation to preservation.
    Teramura S; Yamakado T
    Cardiologia; 1998 Apr; 43(4):375-85. PubMed ID: 9659795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells.
    Yokoshiki H; Katsube Y; Sunagawa M; Sperelakis N
    J Pharmacol Exp Ther; 1997 Oct; 283(1):375-83. PubMed ID: 9336346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation analysis of intracellular Na+ and Cl- homeostasis during beta 1-adrenergic stimulation of cardiac myocyte.
    Kuzumoto M; Takeuchi A; Nakai H; Oka C; Noma A; Matsuoka S
    Prog Biophys Mol Biol; 2008; 96(1-3):171-86. PubMed ID: 17826821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of positive inotropic effects.
    Scholz H
    Basic Res Cardiol; 1989; 84 Suppl 1():3-7. PubMed ID: 2554873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
    Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
    Laine M; Lehtonen L; Nieminen MS
    Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
    [No Abstract]   [Full Text] [Related]  

  • 16. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins.
    Müller-Ehmsen J; Nickel J; Zobel C; Hirsch I; Bölck B; Brixius K; Schwinger RH
    Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of the calcium dependent myocardial contractility to the new cardiotonic agent sulmazole.
    Achenbach C; Ziskoven R; Wiemer J; Hauswirth O
    Arzneimittelforschung; 1984; 34(11):1498-506. PubMed ID: 6543125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative lusitropy and abnormal calcium handling in hypoxic cardiac myocytes exposed to the calcium-sensitizer EMD 53998.
    Webster KA; Bodi I; McNamara JP; Tracy M; Discher DJ; Bishopric NH
    J Mol Cell Cardiol; 1993 Jul; 25(7):747-51. PubMed ID: 8230239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cardiac glycosides on action potential characteristics and contractility in cat ventricular myocytes: role of calcium overload.
    Ruch SR; Nishio M; Wasserstrom JA
    J Pharmacol Exp Ther; 2003 Oct; 307(1):419-28. PubMed ID: 12954807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.